Was your son in the placebo group in the PTC ataluren trial?
PPMD has partnered with researchers at the National Institutes of Health (NIH) for an interview study. The purpose of this study is to describe the experiences of people involved in phase II clinical trials of ataluren for Duchenne muscular dystrophy. We are interested in learning about motivations for being in the clinical trial, expectations of the trial, the experience of the trial, and interactions between families…
ContinueAdded by PPMD on February 1, 2012 at 2:00pm — No Comments
Need help using this community site? Visit Ning's Help Page.
© 2013 Created by PPMD.